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To achieve adequate healing in large or load-bearing bone defects is highly challenging even 




allogeneic bone grafts has many drawbacks. We have developed a bioactive ceramic scaffold, 
strontium-hardystonite-gahnite or “Sr-HT-Gahnite” (a multi-component, calcium silicate-
based ceramic), which when 3D printed combines high strength with outstanding bone 
regeneration ability. In this study, we assess the performance of purely synthetic, 3D printed 
Sr-HT-Gahnite scaffolds in repairing large and load-bearing bone defects. The scaffolds are 
implanted into critical-sized segmental defects in sheep tibia for 3 and 12 months, with 
autologous bone grafts used for comparison. The scaffolds induce substantial bone formation 
and defect bridging after 12 months, as indicated by X-ray, micro-computed tomography, 
histological and biomechanical analyses. Detailed analysis of the bone-scaffold interface using 
focused ion beam scanning electron microscopy and multiphoton microscopy show evidence 
of scaffold degradation and maturation of the newly formed bone. In silico modeling of strain 
energy distribution in the scaffolds reveal the importance of surgical fixation and mechanical 
loading on long-term bone regeneration. The clinical application of 3D printed Sr-HT-Gahnite 
scaffolds as a synthetic bone substitute can potentially improve the repair of challenging bone 
defects, and overcome the limitations of bone graft transplantation. 
 
1. Introduction 
Long bones of the body, particularly the femur and tibia, are the main structures responsible for 
load-bearing during daily activities and are crucial for skeletal mobility. Extensive bone loss 
due to trauma or disease is a major contributor to musculoskeletal disorders that lead to 
disability, frailty and reduced quality of life. A longstanding clinical problem is to achieve 
adequate healing in large or load-bearing bone defects, which is particularly challenging due to 
the impaired ability of bone to repair itself across a ‘critical-sized’ gap, generally 3cm or more 
in humans.[1] Even with surgical intervention, delayed healing or non-union occurs in 5–10% 
of bone fractures,[2] and the non-union of segmental bone defects approaches 100%.[3] 




injuries, are particularly common in young adults and are associated with substantially impaired 
mobility and function.[4] Autologous bone grafts are the current clinical standard for treating 
large bone defects, combining the essential criteria of high bioactivity and strength for inducing 
functional bone regeneration. However, despite excellent outcomes, the use of autologous bone 
grafts has been restricted by significant drawbacks relating to donor site morbidity, insufficient 
supply, and high graft resorption rate.[5,6] The alternative use of allogeneic bone grafts can 
address some of these drawbacks, but are associated with other issues including reduced 
bioactivity and strength due to processing, and poor integration with native bone.[7] 
 
The search for an ideal bone graft substitute material to replace autologous and allogeneic bone 
grafts has drawn increasing interest over the last two decades, but a satisfactory solution has 
not yet been found. The criteria used to assess the properties of synthetic bone substitutes for 
clinical application are based on those exhibited by autologous bone grafts.[8] First, the 
substitute should be highly bioactive, with osteoconductive (can support bone formation on the 
material surface) and ideally osteoinductive (can actively induce new bone formation) 
properties, to promote bone formation without the need to add cells or growth factors. Second, 
the graft should be mechanically strong and provide prolonged support for tissue regeneration 
when implanted in load-bearing defects, and participate in withstanding physiological loads. 
Last, the graft should have the ability to be manufactured through a controlled process and 
possess a reproducible structure, together with high porosity and interconnectivity to ensure 
sufficient nutrient exchange and vascularization that are necessary for supporting bone 
formation and ongoing turnover.  
 
Current synthetic bone substitutes for clinical use are dominated by bioceramics composed of 
calcium phosphates and bioactive glasses, which can at most partially satisfy two of the above 




highly bioactive,[9] while β-tricalcium phosphate and biphasic calcium phosphate lack 
mechanical strength at the range of porosities (50–90%) commonly required for bone 
regeneration.[10] Bioactive glasses generally have poor strength, and their bioactivity may be 
affected by the processing required to form porous scaffolds.[11] For these reasons, current 
clinical applications of bioceramic bone substitutes are limited to particulates for filling bone 
cavities and poorly interconnected blocks with low porosity for grafting small volumes of bone 
loss, typically at non load-bearing sites.[12] There is hence a critical need to develop novel 
synthetic graft materials that can properly address all of the essential criteria and lead to 
improved clinical treatment of highly challenging bone defects. 
 
Over the past five decades, a wide range of synthetic materials have been developed in efforts 
to overcome the above limitations, but none of these have made the genuine transition from 
laboratory to clinic. Among those that have been tested in clinically relevant in vivo models, a 
popular formulation is hydroxyapatite combined with polycaprolactone (PCL) in various 
ratios,[13-16] as well as other calcium phosphate-based compositions.[17-19] Through fabrication 
using additive manufacturing techniques, these implants can generally satisfy the criterion for 
having a controlled structure with fully interconnected pores, although relatively low porosities 
of around 50% are typically required to maintain sufficient strength for load-bearing 
purposes.[15,18] A common challenge is the limited bioactivity of synthetic implants, with most 
studies indicating low or minimal bone formation in critical-sized defects, and the need to 
incorporate cells or growth factors to achieve appropriate healing.[13,14,16,19] This may be a 
limiting factor for the timely translation of such implants into clinical application, since the 
necessity to include biologics introduces additional issues such as donor variations in cell 
behavior, difficulties in determining the appropriate dosage and combination of growth factors, 






In response to these challenges, we combined multiple design strategies to develop a novel, 
multi-component bioceramic known as strontium-hardystonite-gahnite or “Sr-HT-Gahnite”.[20] 
Sr-HT-Gahnite is a calcium silicate-based ceramic with a unique microstructure that forms 
during sintering, consisting of crystalline grains of strontium-hardystonite (Sr–Ca2ZnSi2O7) 
with a wetting glass phase at the grain boundaries, embedded within which are submicron 
gahnite crystals (ZnAl2O4).
[20,21] We have also developed the technology to produce 3D printed 
Sr-HT-Gahnite scaffolds with high porosity (70%) and full interconnectivity (100%).[22] To 
date, we have demonstrated that these scaffolds possess mechanical strength matching cortical 
bone, combined with outstanding bioactivity and ability to induce osteogenesis in vitro and in 
vivo (in rabbits).[20-23] This study is the next step in progressing the Sr-HT-Gahnite scaffolds to 
clinical use, by validating their performance in a clinically relevant large animal model. Here, 
we tested the in vivo ability of 3D printed Sr-HT-Gahnite scaffolds to induce natural 
regeneration in critical-sized segmental defects in the long bones of sheep over one year, 
without the addition of cells or growth factors. We assessed the structural, biomechanical and 
biological outcomes of defect repair, and related these outcomes to observations of microscopic 
material-tissue interactions and modeling of strain energy distribution in the scaffolds. The 
results showed substantial bone formation and defect bridging, indicating that Sr-HT-Gahnite 
scaffolds could be used as an improved synthetic bone substitute, and potentially contribute 
towards solving the clinical dilemma associated with bone graft transplantation. This study also 
revealed important information regarding the influence of factors such as bone-implant 
interactions and mechanical loading on long-term bone repair using synthetic substitutes. 
 
2. Results  




Sr-HT-Gahnite scaffolds used in this study were produced by 3D printing, with dimensions 
fitting the created defects (Figure 1A). The scaffolds had porosity of 70% and were fully 
interconnected, with average pore sizes of 1.1 mm and strut sizes of 0.5 mm, as measured using 
micro-computed tomography (μ-CT).  
 
The study was conducted using a total of 28 sheep, each with a critical-sized, 3 cm long mid-
diaphyseal defect created in the tibia of one hindlimb (Figure 1B). The sheep were divided into 
two cohorts of 14 animals each for the 3 month and 12 month time points. In each cohort, the 
sheep received either a 3D printed Sr-HT-Gahnite scaffold implant (n=8) or autologous bone 
graft (ABG) prepared from the removed tibial bone (n=6). The defect was stabilized using a 
modified 10-hole Dynamic Compression Plate, which was retained until euthanasia.  
 
All animals resumed load-bearing of the experimental limb following surgical recovery. With 
the exception of one animal in the scaffold group, which was euthanized at 18 weeks due to 
welfare concerns not associated with the experimental defect, all other experimental animals 
remained in good health over the duration of the study. All animals receiving the Sr-HT-Gahnite 
scaffolds tolerated the implants well, without clinically significant inflammatory reactions or 
implant failure over the 12 month implantation period. The animals were euthanized at 13 
weeks (8 scaffolds, 6 ABG) or 52 weeks (7 scaffolds, 6 ABG) after surgery. Necropsy revealed 
stable constructs in all animals and no evidence of post-operative complications. 
 
X-ray images of the Sr-HT-Gahnite scaffold group (12 month cohort) were taken at 3 month 
intervals over the implantation period (Figure 1C). The defect borders were less distinguishable 
at 9 and 12 months, and some remodeling of the defect site was evident to restore the original 
shape of the limb. Clinical union was observed at the bone-implant interface beyond 6 months, 





2.2. μ-CT analysis at 3 and 12 months 
μ-CT was used to determine the distribution and volume of new bone in tibial explants 
containing the Sr-HT-Gahnite scaffold or ABG, at 3 and 12 months post-implantation. For the 
scaffold group, at least partial bridging of the defect was achieved in all samples at both 3 and 
12 months. Complete defect bridging by newly formed bone was observed for one of eight 
scaffolds at 3 months, and five of seven scaffolds at 12 months. Representative reconstructed 
images of longitudinal and transverse cross-sections showed that bone formation at 3 and 12 
months within the scaffold-implanted defects followed the same distinct patterns, with new 
bone partly distributed along the defect periphery superficial to the scaffold, and partly within 
the porous structure of the scaffold (Figure 2A). At 12 months, there was a higher volume of 
newly formed bone within the scaffold pores at all locations along the length of the defect 
compared to at 3 months. The patterns of bone distribution suggested that the Sr-HT-Gahnite 
scaffold induced rapid bone growth peripheral to the implant to bridge the defect, concurrent 
with slower bone infiltration into the scaffold pores from the defect edges to fill the empty 
spaces. All samples in the ABG group showed complete bridging at both 3 and 12 months 
(Figure S1), as expected. 
 
The volume of new bone within the defect was determined using quantitative image analysis, 
and was defined as all material above the threshold determined for bone mineral. The scaffold 
group showed a lower volume of new bone compared to the ABG group at 3 months, but 
achieved comparable values to the ABG group at 12 months (Figure 2B). The scaffold group 
also exhibited a trend to an increase in new bone volume from 3 to 12 months, which was 
consistent with the reconstructed cross-sectional images and indicated ongoing repair processes 




at 3 and 12 months, and found to be similar to the pre-implantation scaffold volume, indicating 
the occurrence of only low levels of macroscopic scaffold degradation (Figure 2C). 
 
2.3. Histological analysis at 3 and 12 months 
Tibial explants containing the Sr-HT-Gahnite scaffold or ABG were sectioned and stained to 
allow histological assessment of the nature and quality of new tissue present in the defect at 3 
and 12 months post-implantation. Representative images of whole sections (Figure 3A) 
showed new bone formation advancing into the porous structure of the Sr-HT-Gahnite scaffold 
from both ends of the defect at 3 months, but had not yet occupied the middle section of the 
scaffold. At 12 months, two samples showed complete filling of the spaces within the Sr-HT-
Gahnite scaffold with newly formed bone that was continuous across the entire defect. There 
was some variation in the amount of new bone present in different scaffold samples at both 3 
and 12 months, but all showed substantial bone infiltration into the scaffold. There was no 
evidence of chronic inflammation or fibrous capsule formation surrounding the scaffold in any 
of the samples. Defects implanted using ABG showed complete bridging at 12 months, with 
partial reforming of the original bone architecture that comprised a cortical bone shell and the 
creation of an endocortical marrow space. 
 
At 3 months post-implantation (Figure 3B, C), new bone tissue present within the scaffold was 
dominated by woven bone (purple or dark blue), with a disorganized appearance and frequently 
encompassing multiple types of immature tissue. In some areas, tissue adjacent to the scaffold 
was found to contain mineralized bone surrounding a center region of mineralized cartilage, 
with the latter exhibiting metachromasia (different color) when stained using toluidine blue due 
to its high proteoglycan content (Figure 3B). The woven bone was lined by osteoid (blue edge) 




In other areas of the scaffold particularly at increasing distance from the defect edges, immature 
woven bone was commonly observed with a highly disorganized appearance (Figure 3C).  
 
At 12 months post-implantation (Figure 3D–G), new bone within the scaffold underwent 
increased maturation compared to at 3 months, exhibiting the characteristic appearance of 
lamellar bone and a cortical-like architecture, as well as evidence of ongoing and active bone 
remodeling. An image taken near the defect edge showed the interface between original cortical 
bone and newly formed bone (Figure 3D). The original bone was inactive, highly mineralized 
lamellar bone that was organized into distinct layers. The new bone surrounding the scaffold 
struts was lamellar bone that was richly mineralized but exhibited a disorganized arrangement, 
with no specific orientation. The majority of this new bone stained a darker color with toluidine 
blue compared to the original cortical bone, likely due to its higher proteoglycan content. This 
was particularly evident in the new bone immediately adjacent to the scaffold struts, which 
stained dark purple and was lined with a blue border of unmineralized osteoid, indicative of 
active bone formation. Similar evidence of active bone formation was observed within an 
advancing front of new bone (dark purple lined with blue borders), which was progressing 
upwards to fill the spaces within the scaffold. This process of active bone formation within the 
scaffold was better visualized with the Goldner’s trichrome stain (Figure 3E). Newly formed 
mineralized bone (teal) was seen surrounding the scaffold struts, and was lined with a border 
of osteoid (dark orange) in the area immediately adjacent to the ceramic. An advancing front of 
bone formation was also evident, where unmineralized bone matrix (dark orange) was present 
between the mineralized bone and invading into the loose connective tissue (light orange). This 
was indicative of a continuous process of primary bone formation that would then undergo 
secondary remodeling to form mature mineralized bone, which would eventually fill a 





Closer examination of the new bone within the scaffold revealed longitudinal and transverse 
sections of osteons, consisting of a Haversian canal surrounded by concentric layers of lamellar 
bone (Figure 3F). These Haversian osteons, surrounding a central blood vessel, provided 
evidence of active remodeling to form cortical-like, vascularized bone. This Haversian 
remodeling was better observed in sections stained for tartrate-resistant acid phosphatase 
(TRAP; red stain) to show osteoclast-specific activity (Figure 3G). The osteoclasts were 
localized in the bone immediately adjacent to the scaffold, suggesting that the ceramic 
supported material-cell interactions that might contribute to remodeling of the surrounding bone. 
 
In comparison, the defects implanted with ABG at 12 months post-implantation showed a less 
distinct interface between the original cortical bone and newly formed bone (Figure S2). Highly 
mineralized lamellar bone was present throughout the defect, although the bone became less 
well organized with increasing distance from the edges of the defect. There was some evidence 
of ongoing remodeling in the middle of the defect, compared to mostly inactive bone towards 
the defect edges. A thin border of ongoing bone formation along the defect periphery was 
present. 
 
2.4. Histomorphometric analysis at 3 and 12 months 
Histomorphometric analysis was used to quantitatively assess the extent of bone bridging across 
the defect, and the composition of new tissue formed within the defect, for samples containing 
the Sr-HT-Gahnite scaffold or ABG. The extent of bone bridging across the defect was 
calculated as the percentage of total defect length covered by new bone (Figure 4A). Two 
samples from the ABG group were randomly selected to perform histological and 
histomorphometric analyses at each time point, all of which showed complete defect bridging. 
For the Sr-HT-Gahnite scaffold group, complete bridging was achieved in one of eight samples 




The mean percentage of defect bridging in the scaffold group increased significantly over time, 
from 48% at 3 months to 83% at 12 months. The composition of new tissue within the defect 
was quantitatively assessed at 12 months using Goldner’s trichrome stained sections of samples 
from the Sr-HT-Gahnite scaffold and ABG groups (Figure 4B). The areas occupied by soft 
tissue and mineralized bone were expressed as percentages of total empty space within the 
defect. The scaffold group showed almost complete (80%) filling of the defect with new tissue, 
which was comparable to the ABG group (95%). The composition of this new tissue exhibited 
a higher ratio of mineralized bone to soft tissue in the ABG group compared to the scaffold 
group. There is potential for some of the soft tissue in the scaffold to be replaced by mineralized 
bone over longer time periods, due to evidence from the stained sections showing continuous 
invasion of the soft tissue by newly formed bone. 
 
2.5. Focused ion beam scanning electron microscopy (FIB-SEM) analysis at 3 and 12 
months 
FIB-SEM analysis was performed on the unstained histological sections of tibial explants 
containing the Sr-HT-Gahnite scaffold, at 3 and 12 months post-implantation to allow detailed 
observations of the implant-bone interface. Regions of interest were selected to contain a clear 
view of a scaffold strut, surrounded by newly formed bone and highly cellular loose connective 
tissue (Figure 5A, B). At lower magnification in backscatter SEM imaging, the scaffold 
appeared white and was surrounded by a darker border, which was a zone depleted of certain 
elements due to ion leaching from the ceramic. Surrounding the scaffold strut was a diffuse 
layer of carbon-rich loose connective tissue (dark grey), outside which was mineralized lamellar 
bone containing many osteocyte lacunae. Comparing the images taken at 3 and 12 months 
revealed several differences at the implant-bone interface. At 3 months, the structure of the 
ceramic was well-preserved with no visible surface irregularities. The ring of loose connective 




low degree of organization. At 12 months, the surface contour of the ceramic was less smooth 
and contained many fragmented edges. The darker border around the bulk ceramic had variable 
thickness along its circumference. The surrounding ring of loose connective tissue had 
decreased in thickness, and the adjacent lamellar bone had a much more organized appearance. 
Bone closest to the scaffold had grown in tightly packed, smooth concentric layers, and all of 
the bone appeared to have a higher degree of mineralization compared to that at 3 months. 
These observations suggested an ongoing scaffold degradation process, with ion leaching from 
the borders of the ceramic causing a gradual reduction in scaffold size, which then mediated 
soft tissue infiltration and its eventual replacement by mineralized bone. This was consistent 
with the histological observations that bone formation and remodeling were occurring more 
actively in the areas immediately adjacent to the scaffold struts. 
 
X-ray elemental mapping of the image taken at 12 months showed the distribution of Ca, Al, 
Zn, C, P and O (Figure 5C). The center of the scaffold strut contained mainly Ca, Al, Zn and 
O, which was consistent with the ceramic composition. The ceramic border was rich in Al and 
O, but contained very little Ca and Zn, suggesting that Ca and Zn were the main ions leaching 
from the ceramic during its initial degradation. The dark material surrounding the ceramic 
contained large amounts of C and O, suggesting a highly cellular layer of loose connective 
tissue. The adjacent bone was dominated by Ca and P, which confirmed the presence of mature 
lamellar bone with high mineral content. The C elemental map showed many small spots in the 
bone with positions corresponding to voids in the Ca and P elemental maps, which likely 
represented osteocytes nesting within lacunae in the mineralized bone matrix. 
 
FIB cross-sectioning allowed visualization of the implant-bone interface in nanoscale detail 
(Figure 5D, E). At both 3 and 12 months, the interface showed loose connective tissue (black) 




as a darker border around the bulk ceramic at lower magnification, was actually a zone of 
destruction where parts of the ceramic had disintegrated. At 12 months, the disrupted border 
had a greater thickness than at 3 months, and disintegration of the ceramic was more prominent. 
The loose connective tissue remained on the outside of the disrupted border at 3 months, but 
was able to infiltrate inside the border at 12 months and had reached the level of the bulk 
ceramic. This provided evidence for continuous degradation of the scaffold and gradual 
invasion by newly formed tissue. 
 
2.6. Multiphoton microscopy analysis at 3 and 12 months 
Multiphoton microscopy analysis was performed on the unstained histological sections of tibial 
explants containing the Sr-HT-Gahnite scaffold, at 3 and 12 months post-implantation to 
observe the organization of the bone extracellular matrix (Figure 6). Regions of interest were 
selected at different points along the section to include (1) the original bone, (2) new bone 
within the scaffold near the defect edge, and (3) new bone within the scaffold near the middle 
of the defect. The sections were imaged to specifically visualize the morphology and 
distribution of collagen type I fibers in the bone tissue around and within the scaffold implant. 
The 3 and 12 month sections showed a similar pattern in the arrangement of collagen fibers 
along the length of the defect. In the original bone outside the defect (region 1), the collagen 
fiber network was densely packed and highly organized, with a layered morphology that was 
characteristic of mature lamellar bone. The circular structures likely represented Haversian 
canals that formed a part of the osteons found in cortical bone. In the new bone within the 
scaffold near the defect edge (region 2), the collagen fibers were not aligned as in the original 
bone, but some organization into a layered morphology was evident particularly at 12 months. 
In contrast, new bone within the scaffold near the middle of the defect contained collagen fibers 






Comparing the appearance of collagen fibers in the bone at 3 and 12 months, at similar locations 
along the defect revealed increased bone formation and maturation between the two time points. 
In region 2, collagen in the bone at 12 months was organized into somewhat aligned fiber 
bundles, with a concentric arrangement that was reminiscent of the newly formed, mineralized 
lamellar bone seen in the histology images. In the same region at 3 months, the collagen network 
was less well organized and fiber alignment was only observed in discrete areas, indicating the 
presence of mainly woven rather than lamellar bone at this time. In region 3, the collagen fibers 
were quite densely packed at 12 months but had random orientations, which was characteristic 
of woven bone, compared to at 3 months where they were sparsely distributed and possibly 
indicating the presence of loose connective tissue rather than bone. The increase in density and 
degree of organization of the collagen fibers from the middle to the edge of the defect, and also 
from 3 to 12 months, suggested gradual removal and replacement of the initially formed 
immature bone with more mature new bone. It is likely that following scaffold implantation, 
woven bone is formed first and continually invades the loose connective tissue or empty spaces 
within the scaffold, progressing from the edges of the defect towards the middle. Over time, 
this immature bone is remodeled into mineralized lamellar bone that bears increasing 
resemblance to the original cortical bone, particularly near the defect edges. 
 
2.7. Biomechanical testing at 3 and 12 months 
Biomechanical testing was performed on tibial explants containing the Sr-HT-Gahnite scaffold 
or ABG, at 3 and 12 months post-implantation. At the 3 month time point, only two of the eight 
samples in the scaffold group were tested, as the remaining samples did not achieve sufficient 
stability for testing following plate removal. Biomechanical testing was performed on all 






The torsional stiffness (Figure 7A) and maximum torque (Figure 7B) of test samples implanted 
with the Sr-HT-Gahnite scaffold or ABG were determined, and normalized against values 
obtained for the contralateral, intact tibia. Relative torsional stiffness and maximum torque were 
lower for the scaffold group compared to ABG at both 3 and 12 months, although statistical 
analysis could not be performed at 3 months due to the small sample number in the scaffold 
group. At 12 months, the scaffold group achieved average values of 40% for torsional stiffness 
and 20% for maximum torque relative to the intact tibia, and exhibited some inter-sample 
variation with two of the samples reaching peak values of 70–80% for torsional stiffness and 
30–40% for maximum torque. The scaffold and ABG groups both showed large increases in 
torsional stiffness and maximum torque from 3 to 12 months. 
 
2.8. Strain energy of implanted scaffolds at 12 months 
Mathematical modeling for all defects implanted with the Sr-HT-Gahnite scaffold for 12 
months was performed in silico to understand the influence of mechanical loading on healing 
outcomes. The total elastic strain energy, which reflects the pattern of biomechanical 
stimulation, was quantified in a cross-section located in the center of each scaffold, in the same 
approximate location as the histological sections cut from the explants. X-ray images of 
scaffold-implanted defects at the 12 month time point indicated that there was some variation 
in the arrangement of the fixation plate and screws in each animal, which could result in 
different patterns of mechanical loading being transferred to the scaffold (Figure 8, top panel). 
Another source of variation was the quality of the bone-implant interface, with some visible 
gaps being present in samples 3, 5 and 6. A computational model mimicking the in vivo loading 
regime under walking condition was created for each sample, taking into consideration the 
location of the scaffold and the arrangement of the fixation construct, as determined from the 




pattern of load transfer into the scaffold. The numerical results were then compared with the 
pattern of new bone formation in each sample observed in the stained histological sections 
(Figure 8, middle panel).  
 
The total elastic strain energy in the longitudinal cross-section at the center of each scaffold 
(Figure 8, bottom panel) is shown in the same orientation as the corresponding histological 
section. A direct correlation is evident between the total strain energy and the amount and 
pattern of new bone formed in each defect. In samples 1 and 2, significant strain energy was 
evenly distributed over the majority of the cross-section, due to the non-rigid fixation of screws 
immediately adjacent to the sample. Stress shielding effects were therefore minimal, resulting 
in an even distribution of mechanical stimuli in the scaffold. This was matched by histological 
observations of complete defect bridging and large amounts of mineralized bone formation 
within the scaffold throughout the length of the defect. For samples 3 and 4, even strain energy 
was only found on the right side of the scaffold. On the left side in the region near the plate, 
zero strain energy was generated due to stress shielding, where the completely rigid screw 
fixation caused the majority of the load to be transferred through the plate. Accordingly, 
complete bone bridging was found on the right side of the scaffold in the histological sections, 
while the scaffold area on the left side was completely filled with soft tissue. For sample 5, non-
zero strain energy was only found in the top left corner, corresponding to mineralized bone 
formation just in this region. The zero strain energy in the rest of the cross-section was possibly 
the combined effect of stress shielding due to rigid fixation, and a gap in the bone-scaffold 
interface on the top right. For samples 6 and 7, the scaffold was incompletely filled with soft 
tissue and contained minimal bone, which matched the zero strain on the left side of the cross-
section but was not explained by high strain energy on the right side. Transverse μ-CT cross-
sections revealed a fracture in sample 6 and some scaffold collapse in sample 7 (Figure S3), 




Nevertheless, significant bone bridging along the scaffold periphery was still present in these 
samples, but were not located in the center plane and hence were not intersected by the 
histological section.  
 
These results collectively suggested that new bone formation proceeded optimally in defects 
with physiological levels of significant and evenly distributed loads. Uneven strain distribution 
or low strain due to improper load transfer or implant instability, which might result from 
variations in surgical fixation, could have considerable negative impacts on bone healing. 
 
3. Discussion 
Due to the increasing global incidence of bone injuries and the drawbacks experienced with 
autologous and allogeneic bone grafts, there is an urgent need for the development of improved 
synthetic bone substitutes and their efficient translation into clinical applications.[24] However, 
there are significant difficulties in developing a synthetic graft that simultaneously satisfies the 
regenerative requirements of bone, including bioactivity and ability to promote osteogenesis, 
mechanical properties sufficient for load-bearing, and high porosity and interconnectivity, with 
the practical requirements for clinical use and surgical handling, such as the ability to be 
manufactured with controlled geometry and high reproducibility, and capacity to be used as an 
off-the-shelf implant without needing to incorporate biologics for efficacy. In this study, we 
present the preclinical evaluation of a bioactive ceramic implant composed of Sr-HT-Gahnite 
in the repair of a highly challenging, critical-sized segmental defect in the tibia of sheep over 
12 months, without the addition of cells or growth factors. We show that the Sr-HT-Gahnite 
scaffold implant has potential to satisfy the requirements for a synthetic bone substitute, with 
the ability to achieve significant healing through defect bridging and new bone formation, as 




detailed characterization of the bone-implant interface through FIB-SEM and multiphoton 
microscopy, and mathematical modeling of mechanical loading on the implant and fixation 
construct. 
 
The implanted Sr-HT-Gahnite scaffolds were very well tolerated by all animals over the 12 
month study period. The scaffolds showed a strong ability to induce rapid bridging of the 
critical-sized defect, with complete bridging being achieved in one animal at 3 months, and in 
70% of the animals at 12 months, as confirmed by the μ-CT and histomorphometric data. In 
addition to defect bridging peripheral to the implant, large amounts of new bone formation were 
found within the scaffold pores. The μ-CT data indicated that at 12 months, the volume of 
mineralized bone in defects implanted with the Sr-HT-Gahnite scaffold was comparable to 
those implanted with ABG. Interestingly, histomorphometric analysis at 12 months indicated 
that the total amount of new tissue formed within the defect area was similar between the 
scaffold and ABG groups, but the scaffold group had a comparatively lower ratio of mineralized 
bone to soft tissue. A possible reason for this difference between the outcomes of μ-CT and 
histomorphometric analyses is that μ-CT measurements were based on thresholding for 
mineralized bone over the whole sample, including bone formed peripheral to the implant, 
while histomorphometric measurements were based on one longitudinal cross-section taken 
from the center of each sample, which only included bone ingrowth into the implants. Since the 
Sr-HT-Gahnite scaffold induced rapid bone bridging to occur completely or partially across the 
defect peripheral to the implant, accompanied by the slower ingrowth of new bone through the 
scaffold pores, sections containing the center of the scaffold were expected to contain the least 
amount of mineralized bone in comparison to the other areas. Nevertheless, the histological 
evidence suggested that active bone formation and remodeling activities were ongoing and had 





The outcomes of histological analysis and multiphoton microscopy indicated ongoing 
maturation and remodeling of the new bone formed within the Sr-HT-Gahnite scaffolds. The 
scaffolds appeared to possess both osteoconductive and osteoinductive properties, being able 
to not only support bone growth surrounding the implant and bone bridging on the periphery of 
the defect, but also induce significant invasion of new bone through the scaffold pores from the 
edges towards the center of the defect. As bone formation advanced into the scaffold, woven 
bone with a relatively disorganized structure was initially formed at a rapid rate, which 
constituted the majority of the new bone found within the defect at 3 months. By 12 months, 
the woven bone had been largely replaced by lamellar bone that was continuous across the 
entire defect in some samples. This lamellar bone was highly mineralized and exhibited a well-
organized, cortical-like structure containing features of mature bone such as Haversian osteons 
and lamellar bone. The interface between new bone and ceramic struts of the scaffold appeared 
to be separated by a small gap in most instances, which was filled with a thin layer of soft tissue 
with no evidence of ongoing chronic inflammation or fibrous encapsulation of the implant. 
Osteoclast activity localized in the bone surrounding the ceramic suggested that the scaffold 
might be inducing active bone remodeling in its vicinity. This ongoing remodeling was 
necessary for bone maturation, resulting in the observed transition from woven bone near the 
defect center to earlier formed lamellar bone near the defect interface with original bone, which 
was verified by the arrangement and morphology of bone collagen visualized through 
multiphoton microscopy. Progressing from the center of the defect to the boundaries, the 
collagen network in the newly formed bone within the scaffold changed from a mostly random 
arrangement without a distinct orientation to a highly organized arrangement with layered 
morphology. The ability of the Sr-HT-Gahnite scaffold to support secondary remodeling 
following primary bone formation, through processes analogous to natural fracture healing, 




of anatomically-similar bone tissue to facilitate long-term defect healing and sustained load-
bearing. 
 
Observations from FIB-SEM provided additional insights into the mechanisms of Sr-HT-
Gahnite degradation and its influence on bone formation at the bone-implant interface. At both 
3 and 12 months, there was no evidence of ceramic fretting surrounding the scaffold struts. 
Instead, degradation occurred at the ceramic surface through a two-step process, first by the 
leaching of Ca and Zn ions, followed by the slower removal of a highly disrupted, Al-rich 
border. At 12 months, this border was observed to increase in thickness and allow the 
infiltration of loose connective tissue. The release of Ca and Zn into the spaces surrounding the 
scaffold might be one of the mechanisms contributing to the osteoinductivity of the scaffold, 
by creating a richly mineralized environment that promoted the chemotaxis and osteogenic 
differentiation of osteoprogenitor cells.[26,27] While high concentrations of Al ions have been 
associated with osteomalacia and impaired bone remodeling,[28] elemental mapping in this 
study showed low concentrations of Al ions only on the outer surfaces of the scaffold, and no 
detectable amounts in the surrounding bone or soft tissues. These observations suggested that 
trace amounts of Al ions were released from the scaffold during its degradation and were 
physiologically removed, which eliminates possible concerns regarding toxic build-up of 
aluminum within the defect site. Elemental mapping also suggested that the scaffold struts were 
wrapped by a layer of highly cellular, loose connective tissue rather than directly interfacing 
with the newly formed bone. From 3 to 12 months, the cellular layer had decreased in thickness 
and the bone immediately adjacent to it had been remodeled into a more organized structure. 
Taken together with the histological observations, the likely process of bone formation within 
the Sr-HT-Gahnite scaffold was ceramic degradation causing the ingrowth of soft tissue, 
followed by replacement of the soft tissue with woven bone that was gradually converted into 




formed bone to the implant surface,[25,29] the ability of the Sr-HT-Gahnite scaffold to maintain 
a cellular layer between the ceramic and new bone might be beneficial for long-term healing. 
Rather than being incorporated into the newly formed bone, the scaffold can facilitate ongoing 
cell-mediated ceramic degradation through the cellular layer, which is accompanied by active 
bone formation and remodeling adjacent to the implant.[30] 
 
Other than structural healing of the defect with cortical-like bone, the Sr-HT-Gahnite scaffolds 
also achieved considerable functional restoration of the implanted limb at 12 months. The 
scaffolds possessed pre-implantation compressive strength that was within the range of values 
reported for cortical bone,[22] which was sufficient for supporting physiological loads 
immediately post-implantation and throughout the duration of the study. Although the scaffold 
group did not reach the same biomechanical properties as the ABG group, the values obtained 
at 3 and 12 months had greatly outperformed other scaffold-only implants tested as bone graft 
substitutes in similar ovine defect models.[13,14,16,25] The scaffold-implanted defects showed a 
large increase in biomechanical properties from 3 to 12 months, suggesting a gradual 
strengthening process that was consistent with the maturation of new bone observed through 
histology and multiphoton microscopy. Slow in vivo degradation of the scaffold was 
advantageous for long-term defect healing, by facilitating physiological load transfer over 
extended periods of time, thereby providing ongoing mechanical support and stimulation for 
bone growth and remodeling to occur.  
 
Other than characteristics of the scaffold itself, the method of surgical implantation and fixation 
probably plays an equally significant part in influencing the outcomes of bone regeneration. It 
is long known that mechanical strains generated from loads placed on a scaffold are intimately 
linked to cellular responses and tissue regeneration,[31] and mechanical loading can act as an 




shielding in the implant, thereby altering the patterns of strain distribution and having a direct 
impact on the outcomes of bone regeneration in clinically relevant defects.[32] As observed in 
this study, the rigidity of the fixation system and the quality of the bone-implant interface had 
profound effects on subsequent implant loading. This led to inter-sample variations in the 
healing outcomes, where implants with the most even strain distribution also had the highest 
biomechanical properties and greatest amount of bone formation, which were comparable to 
the results obtained using autologous bone grafts. These outcomes indicate that long-term 
implant stability and minimal stress shielding are essential for producing satisfactory healing in 
load-bearing long bones. 
 
One of the limitations of this study was that the cylindrical Sr-HT-Gahnite scaffolds did not 
allow proper remodeling into anatomically-similar long bone with a cortical shell and 
endocortical marrow space. This limitation can be addressed in the future by 3D printing the 
scaffold in the shape of a hollow tube to replicate the native anatomy. The implanted scaffold 
can then exist as a semi-permanent implant to provide support for ongoing defect repair and 
bone remodeling. To minimize inter-sample variations in bone regeneration and ensure 
consistent and optimal healing, future studies should compare surgical implantation and 
fixation methods for maximizing treatment outcomes using the Sr-HT-Gahnite scaffold. A 
practical limitation of this study was that the same specimen from each animal was used for 
biomechanical testing, μ-CT imaging, and histological and histomorphometric analyses (in this 
sequence), to avoid the need to use multiple animals for different evaluation methods. 
Biomechanical testing might have resulted in spiral fractures through the specimens, which 
were clearly identifiable in some of the histological sections, such as the 12 month ABG section 
in Figure 3A. These fractures might have affected the macroscopic appearance of the specimen 




Detailed quantitative histomorphometric analyses were conducted only on regions not affected 
by the fractures. 
 
The findings of this study suggest that 3D printed Sr-HT-Gahnite scaffolds have capacity to 
induce complete bone regeneration and defect healing in a highly challenging, critical-sized 
segmental defect that may not normally heal even with surgical intervention, without the need 
to incorporate cells or growth factors. To date, this achievement has never been observed for 
scaffold-only implants used as synthetic bone substitutes in clinically relevant defect models. 
Mathematical modeling revealed that surgical placement and appropriate implant fixation had 
equal importance as the inherent implant characteristics in maintaining long-term implant 
stability, seamless bone-implant integration, and physiological load transfer, factors which all 
had a potentially profound effect on the outcomes of bone healing.  
 
4. Conclusion 
With consistent and optimized surgical implantation techniques, Sr-HT-Gahnite scaffolds may 
have significant potential for clinical use as a purely synthetic bone substitute that can match 
the structural and functional outcomes of bone regeneration achieved with autologous bone 
grafts. The ability to produce off-the-shelf, cost-effective and patient-specific Sr-HT-Gahnite 
scaffolds, which are highly bioactive and able to induce complete healing in large or load-
bearing bone defects, will bring significant potential to augment or substitute current surgical 
approaches for bone repair using autologous or allogeneic bone grafts. 
 
5. Experimental Section 
Fabrication of Sr-HT-Gahnite scaffolds: All reagents were purchased from Sigma-Aldrich, 
USA unless otherwise specified. Precursor ceramic powder for producing 3D printed Sr-HT-




prepared using the sol-gel method, with 15 wt% aluminum oxide (Al2O3) powder, as previously 
described.[20] The powder was ground using a ball mill machine (Retsch PM 400, Germany) to 
obtain median particle sizes of 1 μm.  
 
Sr-HT-Gahnite scaffolds with rectangular pore geometry were fabricated by 3D printing, as 
previously described.[22] Briefly, the ink was formulated by dispersing the precursor ceramic 
powder in a water-based organic solution. The ink was printed through a 600 μm custom-made 
nozzle using a robotic deposition device (Hyrel 3D, USA). A controlled heat treatment was 
used to decompose the organic materials in the printed scaffolds and sinter the ceramic particles 
to form dense struts. The unique microstructure of Sr-HT-Gahnite scaffolds forms during this 
process, consisting of strontium-hardystonite grains (Sr–Ca2ZnSi2O7) and a glass phase at the 
grain boundaries containing submicron gahnite crystals (ZnAl2O4). The green samples were 
heated at 1°C/min to 450°C, followed by densification at 1250°C for 3 hours. The prepared 
scaffolds were cylindrical (diameter 20 mm, height 30 mm), with porosity of 70% and fully 
interconnected pores. 
 
Surgical procedures for creation and implantation of critical-sized segmental defects in sheep 
tibia: All procedures were approved by the animal ethics committee at the Queensland 
University of Technology, Brisbane, Australia (approval number 1400000025). A critical-sized 
defect was created in the right tibia of 28 Merino wethers (weight 45.6 ± 5.7 kg, age 3-4 years), 
according to previously described and well-established methods.[33] Briefly, during surgery 
under general anesthesia, aseptic conditions and using a bimodal analgesics regime, a 3 cm 
segment of the mid-diaphyseal tibia was removed through a medial approach, and the defect 
was stabilized using a modified 10-hole Dynamic Compression Plate (Synthes, 
Switzerland). The defect was filled with either a 3D printed Sr-HT-Gahnite scaffold (n=16), or 




thickness segments removed from the tibia (n=12), and the surgical wound was closed in layers. 
After surgery, a full-length fiberglass cast (Delta-Lite Plus, BSN medical) was applied to the 
operated limb to offer protection from excessive loading during the first 4 weeks of 
healing.  Following cast removal, the animals were allowed to mobilize freely for the remaining 
duration of the study.  X-ray images (Philips Veradius, Royal Philips, The Netherlands) were 
taken immediately post-operation, and then at 6 weeks, 3 months, 6 months, 9 months and 12 
months. At the 3 month and 12 month time points, half of the animals from each group were 
euthanized, and the experimental limbs were explanted for further processing and analysis. 
 
Biomechanical testing: Following sacrifice, the experimental and contralateral tibiae of each 
animal were explanted, and the fixation plate and screws were carefully removed from the 
experimental limb. For each sample, both tibial ends were embedded in dental acrylic 
(Palapress, Heraeus Kulzer, Germany), and the sample was then mounted in a biaxial 
mechanical testing machine (Instron 8874, Instron, Norwood MA, USA). The torsional stiffness 
and maximum torque were determined in internal rotation at an angular velocity of 0.5°/s. 
Results from the experimental tibiae were normalized against values obtained for the 
contralateral, intact tibiae to account for inter-individual differences. The samples were fixed 
in 10% neutral buffered formalin before further processing. 
 
Micro-computed tomography (μ-CT): Prior to implantation, two of the Sr-HT-Gahnite scaffolds 
were scanned in a µ-CT scanner (µCT40, Scanco Medical, Bassersdorf, Switzerland). The X-
ray tube was operated at 70 kV and 114 µA with 200 ms integration time, resulting in a voxel 
size of 36 µm. The scaffolds were segmented using a lower threshold of 1328.2 mg HA/ccm 
from the scans, and their morphological parameters were determined using the scanner’s 





Following biomechanical testing of the tibial samples, the mid-diaphyseal section of each 
sample containing the defect was prepared for µ-CT.  To determine new bone formation in the 
defect zone, scanning of the samples was performed using the same equipment and procedures 
as described above. Newly formed bone was distinguished from the scaffold material using a 
lower threshold of 508.1 mg HA/ccm and an upper threshold of 1328.2 mg HA/ccm, both with 
a Gaussian filter of sigma 1.8 and support of 3.0 using the scanner’s software (µCT Evaluation 
v6.6).  
 
Histological and histomorphometric analyses: Following μ-CT evaluation, the tibial samples 
were processed for histology. Samples were dehydrated through graded ethanol, cleared in 
xylene, and embedded in methyl methacrylate resin (Technovit 9100, Kulzer, Germany). 
Longitudinal thick sections (>250 μm thickness) were cut from each sample using a diamond 
saw (EXAKT, USA), and ground sections (30–50 μm thickness) were obtained through 
grinding (EXAKT microgrinder) and polishing (Tegramin polisher, Struers). The sections were 
stained using toluidine blue or Goldner’s trichrome, and visualized using a Zeiss Axio Imager 
2 microscope (Carl Zeiss, Germany). To visualize tartrate-resistant acid phosphatase (TRAP) 
enzyme activity, the sections were stained using a TRAP Staining Kit (Cosmo Bio, Japan), prior 
to counter-staining using toluidine blue. 
 
Histomorphometric measurements were performed using a Goldner’s trichrome stained section 
from each sample, and quantified using the Osteomeasure software (OsteoMetrics, USA). The 
defect area in each section was selected by defining the proximal and distal defect boundaries 
according to discontinuities in the structure of the lamellar bone (Figure S4). If bone bridging 
across the defect was incomplete, the percentage bridging was calculated by measuring the 
distance of penetration into the defect area by newly formed mineralized bone from both 




areas occupied by soft tissue (orange) and mineralized bone (teal) in the total defect area were 
quantified using the software. 
 
Focused ion beam scanning electron microscopy (FIB-SEM): Unstained histological sections 
were sputter-coated with 50 nm of amorphous carbon for charge dissipation. Focused ion beam 
(FIB) cross-sectioning and scanning electron microscopy (SEM) were performed using an FEI 
Helios 660 Dual-Beam FIB-SEM. The FIB was operated at 30 kV accelerating voltage and 9.5 
nA probe current for coarse milling, with final polishing performed at 0.79 nA. SEM imaging 
was performed either at 20 kV using a photodiode backscatter detector, or at 3 kV in field-
immersion mode using an in-column backscatter detector. For FIB processing, a protective 
layer of Pt was deposited in-situ to minimize curtaining effects and prevent surface erosion. 
 
Multiphoton microscopy: Unstained histological sections were imaged without pre-labeling 
using two-photon microscopy. A TriMScope II (LaVision BioTec, Germany) was used, which 
was based on a Nikon Eclipse Ti-E inverted stage and equipped with an ultra-short pulsed Ti:Sa 
laser (t < 150 fs, repetition rate: 80 MHz; Chameleon Vision II, Coherent, USA), with 
dispersion pre-compensation and tunable wavelengths (λ=710-980 nm). Laser excitation 
occurred at λ=810 nm. The signals were collected using a 40× UV-vis-IR water immersion 
objective (LD C-apochromat, N.A.: 1.1, WD: 0.62; Zeiss, Germany) and separated by a dichroic 
mirror (460DCXR, Chroma Technology, USA). Wavelengths >460 nm were derived from 
cellular autofluorescence (AF) and detected in channel 1 (not shown). Wavelengths <460 nm 
were reflected, blocked using a bandpass filter (405/20, Chroma), and recorded as Second 
Harmonic Generation signals (SHG) from collagen-I fiber networks in channel 2. Detection 
occurred with high-sensitivity GaAsP photomultipliers (H7422-40, Hamamatsu Photonics, 




objective. The laser intensities and detector voltages were adapted for optimal signal quality in 
both channels. Images were analyzed using Fiji software (NIH, USA). 
 
Mathematical modeling of strain energy: Mathematical modeling of total elastic strain energy 
in the implanted Sr-HT-Gahnite scaffolds was performed by reconstructing a μ-CT based sheep 
tibia model, and inserting a computer aided design scaffold model to closely mimic the in vivo 
placement of the scaffold in the bone defect and arrangement of the fixation device in each 
animal. Finite element analysis was performed on each sheep tibia model, and the total elastic 
strain energy was presented by taking a longitudinal cross-section at the center of the scaffold. 
Detailed computational modeling methods (Figure S5) are included in the Supporting 
Information. 
 
Statistical analysis: Data were represented as mean ± standard deviation. The significance of 
differences between groups was assessed using a t-test with p < 0.05 taken to indicate 
significance. For box plots, data were represented as median, first quartile, and third quartile, 
with the error bars indicating maximum and minimum values. 
 
Supporting Information  
Supporting Information is available from the Wiley Online Library or from the author. 
 
Acknowledgements 
The authors thank the following staff from the Queensland University of Technology: the 
Medical Engineering Research Facility (MERF) for veterinary assistance and technical support, 
the Central Analytical Research Facility for assistance in conducting the histological analyses, 
and Dr Caroline Grant for donating the μ-CT scans of the sheep tibia. The authors acknowledge 
the following funding sources: The Australian Research Council (IC170100022), the Australian 
National Health and Medical Research Council (APP1107470 and APP1120249), and the 
Rebecca L. Cooper Medical Research Foundation, Australia; Center for Nanoscale Systems, a 
member of the National Nanotechnology Coordinated Infrastructure Network and a part of 
Harvard University, supported by the National Science Foundation (NSF Award No. 1541959), 
USA; Friedrich-Alexander University Erlangen-Nürnberg, supported by the Emerging Fields 




Universities Australia mobility exchange grant scheme, Germany/Australia; the AO 
Foundation (Project No. S-14-97R), Switzerland.  
 
Received: ((will be filled in by the editorial staff)) 
Revised: ((will be filled in by the editorial staff)) 
Published online: ((will be filled in by the editorial staff)) 
 
References 
[1] C. A. Garrido, S. E. Lobo, F. M. Turibio, R. Z. LeGeros, Int. J. Biomater. 2011, DOI: 
10.1155/2011/129727. 
[2] J. I. Dawson, R. O. C. Oreffo, Arch. Biochem. Biophys. 2008, 473, 124-131. 
[3] P. R. Stafford, B. L. Norris, Injury 2010, 41, Suppl 2, S72-S77. 
[4] K. A. Alberts, G. Loohagen, H. Einarsdottir, Injury 1999, 30, 519-523. 
[5] E. D. Arrington, W. J. Smith, H. G. Chambers, A. L. Bucknell, N. A. Davino, Clin. 
Orthop. Relat. Res. 1996, 329, 300-309. 
[6] J. C. Banwart, M. A. Asher, R. S. Hassanein, Spine 1995, 20, 1055-1060. 
[7] A. S. Greenwald, S. D. Boden, V. M. Goldberg, Y. Khan, C. T. Laurencin, R. N. Rosier, 
J. Bone Jt. Surg., Am. Vol. 2001, 83A, S98-S103. 
[8] Y. Liu, J. Lim, S.-H. Teoh, Biotechnol. Adv. 2013, 31, 688-705. 
[9] S. Samavedi, A. R. Whittington, A. S. Goldstein, Acta Biomater. 2013, 9, 8037-8045. 
[10] A. J. Wagoner Johnson, B. A. Herschler, Acta Biomater. 2011, 7, 16-30. 
[11] Q. Fu, E. Saiz, M. N. Rahaman, A. P. Tomsia, Mater. Sci. Eng., C 2011, 31, 1245-1256. 
[12] J. J. Li, D. L. Kaplan, H. Zreiqat, J. Mater. Chem. B 2014, 2, 7272-7306. 
[13] A. Berner, J. C. Reichert, M. A. Woodruff, S. Saifzadeh, A. J. Morris, D. R. Epari, M. 
Nerlich, M. A. Schuetz, D. W. Hutmacher, Acta Biomater. 2013, 9, 7874-7884. 
[14] A. Cipitria, J. C. Reichert, D. R. Epari, S. Saifzadeh, A. Berner, H. Schell, M. Mehta, 




[15] A. E. Jakus, A. L. Rutz, S. W. Jordan, A. Kannan, S. M. Mitchell, C. Yun, K. D. Koube, 
S. C. Yoo, H. E. Whiteley, C.-P. Richter, R. D. Galiano, W. K. Hsu, S. R. Stock, E. L. 
Hsu, R. N. Shah, Sci. Transl. Med. 2016, 8, 358ra127. 
[16] J. C. Reichert, A. Cipitria, D. R. Epari, S. Saifzadeh, P. Krishnakanth, A. Berner, M. A. 
Woodruff, H. Schell, M. Mehta, M. A. Schuetz, G. N. Duda, D. W. Hutmacher, Sci. 
Transl. Med. 2012, 4, 141ra93. 
[17] C. Harms, K. Helms, T. Taschner, I. Stratos, A. Ignatius, T. Gerber, S. Lenz, S. 
Rammelt, B. Vollmar, T. Mittlmeier, Int. J. Nanomed. 2012, 7, 2883. 
[18] S. Reitmaier, A. Kovtun, J. Schuelke, B. Kanter, M. Lemm, A. Hoess, S. Heinemann, 
B. Nies, A. Ignatius, J. Orthop. Res. 2017, 36, 106-117. 
[19] J. R. Field, M. McGee, R. Stanley, G. Ruthenbeck, T. Papadimitrakis, A. Zannettino, S. 
Gronthos, S. Itescu, Vet. Comp. Orthop. Traumatol. 2011, 24, 113-121. 
[20] S. I. Roohani-Esfahani, C. R. Dunstan, J. J. Li, Z. Lu, B. Davies, S. Pearce, J. Field, R. 
Williams, H. Zreiqat, Acta Biomater. 2013, 9, 7014-7024. 
[21] S.-I. Roohani-Esfahani, Y. Chen, J. Shi, H. Zreiqat, Mater. Lett. 2013, 107, 378-381. 
[22] S.-I. Roohani-Esfahani, P. Newman, H. Zreiqat, Sci. Rep. 2016, 6, 19468. 
[23] J. J. Li, S.-I. Roohani-Esfahani, K. Kim, D. L. Kaplan, H. Zreiqat, J. Tissue Eng. 
Regener. Med. 2017, 11, 1741-1753. 
[24] A. Bigham‐Sadegh, A. Oryan, Int. Wound J. 2014, 12, 238-247. 
[25] J. J. Li, S.-I. Roohani-Esfahani, C. R. Dunstan, T. Quach, R. Steck, S. Saifzadeh, P. 
Pivonka, H. Zreiqat, Biomed. Mater. 2016, 11, 015016. 
[26] A. M. C. Barradas, H. A. M. Fernandes, N. Groen, Y. C. Chai, J. Schrooten, J. van de 
Peppel, J. P. T. M. van Leeuwen, C. A. van Blitterswijk, J. de Boer, Biomaterials 2012, 
33, 3205-3215. 
[27] M. M. Dvorak, D. Riccardi, Cell Calcium 2004, 35, 249-255. 




[29] J. J. Li, A. Akey, C. R. Dunstan, M. Vielreicher, O. Friedrich, D. C. Bell, H. Zreiqat, 
Adv. Healthcare Mater. 2018, 7, 1800218. 
[30] C. Kunert-Keil, F. Scholz, T. Gedrange, T. Gredes, Ann. Anat. 2015, 199, 79-84. 
[31] D. P. Byrne, D. Lacroix, J. A. Planell, D. J. Kelly, P. J. Prendergast, Biomaterials 2007, 
28, 5544-5554. 
[32] A.-M. Pobloth, S. Checa, H. Razi, A. Petersen, J. C. Weaver, K. Schmidt-Bleek, M. 
Windolf, A. Á. Tatai, C. P. Roth, K.-D. Schaser, G. N. Duda, P. Schwabe, Sci. Transl. 
Med. 2018, 10, eaam8828. 
[33] J. C. Reichert, D. R. Epari, M. E. Wullschleger, S. Saifzadeh, R. Steck, J. Lienau, S. 
Sommerville, I. C. Dickinson, M. A. Schütz, G. N. Duda, D. W. Hutmacher, Tissue 
Eng., Part B 2010, 16, 93-104. 
[34] W. R. Taylor, B. M. Poepplau, C. König, R. M. Ehrig, S. Zachow, G. N. Duda, M. O. 
Heller, J. Orthop. Res. 2011, 29, 567-571. 
[35] H.-C. Spatz, E. J. O'Leary, J. F. V. Vincent, Proc. Biol. Sci. 1996, 263, 287-294. 
[36] A. Entezari, S.-I. Roohani-Esfahani, Z. Zhang, H. Zreiqat, C. R. Dunstan, Q. Li, Sci. 
Rep. 2016, 6, 28816. 
[37] A. Entezari, Z. Zhang, A. Sue, G. Sun, X. Huo, C.-C. Chang, S. Zhou, M. V. Swain, Q. 
Li, J. Mech. Behav. Biomed. Mater. 2018, DOI: 10.1016/j.jmbbm.2018.08.034. 
[38] B. Hassani E. Hinton, Comput. Struct. 1998, 69, 707-717. 






Figure 1. Sr-HT-Gahnite scaffold implant, surgical procedure, and post-operative X-ray 
images. (A) 3D printed Sr-HT-Gahnite scaffolds were used for implantation. The scaffolds had 
controlled geometry and a highly porous and fully interconnected structure, as shown 
macroscopically and through μ-CT imaging. The scaffolds were manufactured with dimensions 
matching the defect size in the sheep tibia. (B) Surgical procedure for implanting the Sr-HT-
Gahnite scaffold into the bone defect. A critical-sized, 3cm long mid-diaphyseal defect was 
created in the tibia of the experimental animal. The defect was stabilized using a modified 10-
hole Dynamic Compression Plate, and the scaffold was implanted into the defect by press-
fitting. For defects implanted with autologous bone graft, the excised tibial bone segment was 
morselized using a bone mill to generate autologous bone chips, which were packed into the 
defect. (C) Representative X-ray images taken over the duration of the 12 month in vivo study, 






Figure 2. μ-CT analysis of new bone distribution and volume at 3 and 12 months. (A) 
Representative reconstructed images of longitudinal and transverse cross-sections of defects 
implanted with the Sr-HT-Gahnite scaffold at 3 and 12 months. Red = bone, white = scaffold. 
(B) Volume of new bone at 3 and 12 months for defects implanted with the Sr-HT-Gahnite 
scaffold (n=8 at 3 months, n=7 at 12 months) or ABG (n=6). *p < 0.05, two-tailed t-test.  (C) 






Figure 3. Histological assessment of new bone within the treated defects at 3 and 12 months. 
Sections were stained with toluidine blue unless otherwise specified. NB = new bone, CB = 
original cortical bone, S = scaffold. (A) Representative whole sections showing defects 
implanted with the Sr-HT-Gahnite scaffold at 3 and 12 months, and autologous bone graft 




mostly immature woven bone, with evidence of active bone formation and osteoid (black 
arrows) lining the new bone. (D–G) At 12 months post-implantation, large areas within the 
scaffold were filled with mature mineralized bone. (D) The interface between original cortical 
bone and newly formed bone showed a transition from highly organized to more randomly 
orientated lamellar bone (purple). An advancing front of bone formation (yellow arrows) was 
progressing upwards to fill spaces within the scaffold, containing newly formed mineralized 
bone (dark purple) lined by osteoid (dark blue borders). (E) Goldner’s trichrome stain showing 
mineralized bone (teal) within the scaffold, also with an advancing front of bone formation 
(yellow arrows) lined by osteoid (dark orange), which was invading upwards into the loose 
connective tissue (light orange). (F) New bone within the scaffold had undergone secondary 
remodeling to form osteons with a central Haversian canal, the longitudinal (yellow rectangles) 
and transverse (yellow circles) sections were evident. (G) Tartrate-resistant acid phosphatase 
(TRAP) staining (red) showed osteoclast-specific activity localized in the bone surrounding the 






Figure 4. Histomorphometric analysis of bone bridging and composition of new tissue within 
the treated defects. Goldner’s trichrome stained sections were used to analyze samples 
containing the Sr-HT-Gahnite scaffold (n=8 at 3 months, n=7 at 12 months) or ABG (n=2). (A) 
Percentage of the defect length bridged by new bone for the scaffold and ABG groups at 3 and 
12 months. *p < 0.05, two-tailed t-test. (B) Composition of new tissue within the defect area 
for the scaffold and ABG groups at 12 months, expressed as percentages occupied by soft tissue 






Figure 5. Focused ion beam scanning electron microscopy (FIB-SEM) analysis of sample 
sections containing the Sr-HT-Gahnite scaffold at 3 and 12 months. B = new bone, S = scaffold 
strut, * = loose connective tissue. (A, B) Lower magnification images showing newly formed 
bone and loose connective tissue surrounding the scaffold strut, which had a darker border 
indicative of ceramic degradation (between yellow arrows). (C) Elemental maps of the image 
in (B), showing the distribution of Ca, Al, Zn, C, P and O. Scale bar = 100 μm. (D, E) FIB-
SEM cross-sections of the implant-bone interface, showing details of the scaffold strut and 
loose connective tissue, between which was a disrupted border (between yellow arrows) 
representing a zone of ceramic disintegration. At 12 months, this border became more 






Figure 6. Multiphoton microscopy analysis of sample sections containing the Sr-HT-Gahnite 
scaffold at 3 and 12 months. Images show the morphology and distribution of collagen type I 
fibers at different implant locations: (1) in the original bone, (2) within the implant near the 







Figure 7. Biomechanical properties at 3 and 12 months. (A) Torsional stiffness and (B) 
maximum torque were determined for tibial samples implanted with the Sr-HT-Gahnite 
scaffold (n=2 at 3 months, n=7 at 12 months) or ABG (n=6), and normalized against values 






Figure 8. Mathematical modeling of total strain energy for defects implanted with the Sr-HT-
Gahnite scaffold at 12 months post-implantation. X-ray images show the arrangement of the 
fixation plate and screws, and the bone-implant interface (yellow arrows = gaps) in each animal 
(top panel). Histological images of whole sections stained with Goldner’s trichrome (middle 
panel) are included for comparison with the numerical results of total strain energy in the 







Sr-HT-Gahnite scaffolds showed strong ability to repair large and load-bearing defects in the 
long bones of sheep over one year, without the addition of cells or growth factors. These 3D 
printed bioactive ceramic implants may be useful as purely synthetic bone substitutes to 
augment the clinical treatment of challenging bone defects. 
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Supplementary Experimental Section 
Mathematical modeling of strain energy: An intact sheep tibia was scanned to reconstruct the 
μ-CT based tibia model required for the numerical analyses. Reconstructed images were 
imported into the image-processing software ScanIP (Simpleware Ltd, Exeter, UK). A proper 
threshold range for bone segmentation was selected by careful inspection of the grayscale 
images. A Recursive Gaussian filter with 32 μm was applied as a typical smoothing tool. A 
surface model was created from the segmented bone and saved as a STL file, which was 
imported into Space Claim (SCDM 17.0) for converting the surface model into a solid model. 
 
Finite element analyses (FEA) were performed using ABAQUS 6.13 (SIMULIA, Providence, 
RI, USA). The numerical models were created to closely mimic the in vivo implantation of the 
scaffold in each animal. The location of the scaffold and arrangement of the fixation plate and 
screws were determined from X-ray images taken at 12 months post-implantation. The X-ray 
images indicated that in most samples, all of the screws were locked and were not able to slide 
in the grooves of the plate, thereby creating rigid fixation. However, a portion of the screws in 
some of the samples were free to slide in the grooves of the plate, which were modeled by 
assuming a friction coefficient of 0.5 between the screw and the plate in FEA.  The X-ray 




could have changed the load transfer and affected their contact with the surrounding tibial bone. 
These structural imperfections were considered when in the corresponding finite element 
models and analyses. 
 
For each sample, the distal end of the μ-CT reconstructed tibia model was fixed, and a total 
force of 300 N was applied on the tibial condylar surface to simulate walking condition.[34] A 
mid-shaft defect (3 cm long) was created to match the in vivo defect location. The computer 
aided design (CAD) model of the scaffold (3 cm high) was designed to reflect the geometry of 
actual scaffolds used for in vivo implantation. The geometry of the plate and screws were 
modeled from careful measurements of the actual plate and screws used in vivo. To balance the 
accuracy and efficiency of the finite element modeling, a mesh convergence analysis was 
conducted to determine the size of 4-node linear tetrahedron elements. The cortical bone was 
assumed to be homogenous and isotropic, with Young’s modulus of 19.6 GPa.[35] The plate and 
screws were made of stainless steel, with Young’s modulus of 180 GPa. The base material of 
the scaffolds (Sr-HT-Gahnite) was assumed to be isotropic, with Young’s modulus and 
Poisson’s ratio of 33 GPa and 0.36, respectively.[36] 
 
To reduce computational costs, detailed scaffold models were replaced with homogeneous solid 
models of the same size, with equivalent (effective) anisotropic material properties.[37] Since 
the 3D printed scaffold was a periodic structure made by the repetition of a representative 
volume element (RVE), an asymptotic homogenization technique based on periodic boundary 
conditions was adopted to determine the equivalent (effective) anisotropic material properties 
of the scaffolds. The primary idea of the asymptotic homogenization refers to averaging the 
field variable, such as displacement, within a RVE Ω, which periodically extends itself in space 
to predict the effective physical properties.[38] For an elastic problem, the deformation is 
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where U0, U1 and U2 represent the field in the 0th, 1st and 2nd order, and are for the small but 
positive scale factor 0 < ε << 1. The microscopic (local) coordinate system and macroscopic 
(global) coordinate system are given by x = [x1, x2, x3]
T and y = [y1, y2, y3]
T, respectively. The 
effective elastic tensor is given by:[39] 
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                                      (2) 
where 
 
  is the volume of the 3D RVE; ijmnD  is the elasticity tensor of the base material (Sr-
HT-Gahnite); 
 
  is the volume fraction of solid phase within a local finite element centered at 
a point x  (thus solid and void elements are represented as 
 
 =1 and 
 
 = 0 , respectively, 
in this framework); and ( )klmn
0  are linearly independent unit test strains applied to the RVE to 
determine the characteristic strain fields, ( )klmn
* . Six test strains were applied, and the 
characteristic strain can be obtained from the following equation: 
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 
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The analysis was conducted on the commercial FEA code ANSYS platform with Parametric 
Design Language (APDL). Periodic boundary conditions were imposed by designating the 







Figure S1. Representative μ-CT image reconstruction of a tibial defect implanted with 
autologous bone graft at 3 months post-implantation. Complete bridging of the defect, similar 
to that shown in this figure, was achieved in all samples implanted with autologous bone graft 




Figure S2. Histological images of defects implanted with autologous bone graft at 12 months 
post-implantation, stained using toluidine blue. (A) The interface between original cortical bone 
(right) and newly formed bone (left) was not clearly distinguishable. New bone near the defect 
edge was highly mineralized and not undergoing active remodeling. (B) New bone in the middle 
of the defect was highly mineralized but had a more disorganized appearance. There was some 






Figure S3. Transverse μ-CT cross-sections for (A) sample 6 and (B) sample 7 from Figure 8, 
taken from the middle of the sample. Despite significant bone formation in these samples, the 
bone was not present in the center plane in the longitudinal direction, leading to minimal bone 




Figure S4. Method of conducting histomorphometric analysis using Osteomeasure. (A) Sample 
sections were stained using Goldner’s trichrome (orange = soft tissue, teal = mineralized bone). 
(B) The defect area (grey) was selected by defining the proximal and distal defect boundaries. 
(C) If bone bridging was incomplete, the distance of penetration into the defect area (yellow 
lines) by newly formed mineralized bone was measured from both the proximal and distal 
defect boundaries. (D) The total length of the defect area (pink line) was then measured to 






Figure S5. Mathematical modeling to determine total strain energy in the Sr-HT-Gahnite 
scaffolds. (A) The computer aided design (CAD) model of a porous scaffold. (B) A solid block 
having homogenized material properties equivalent to the porous scaffold. (C) The CAD model 
of a scaffold implanted into a 3cm defect in sheep tibia, stabilized using fixation plate and 
screws. (D) The contour of von Mises stress distribution in the model. (E) The contour of total 
elastic strain energy in the scaffold. (F) The contour of total elastic strain energy in a cross-
section located at the center of the scaffold. 
 
 
 
